Publications by Medical Specialty - Cardiology
These publications were authored or co-authored by Quest Diagnostics staff.
- Clinical and Lab healthcare professionals
- Endocrinology, Diabetes & Metabolism
- Family medicine practitioners
- General Health and Wellness
- Geriatrics/Age Management
- Health Information Technology
- Infectious Disease
- Internal Medicine
- Nurse practitioners
- Pathology, Anatomic
- Pathology, Laboratory Medicine
- Physician assistants
- Sports Medicine
- Toxicology/Pain Management
- Women's Health/OB/GYN
Low-Density Lipoprotein Particle Number Is Associated With Cardiovascular Events Among Those Not Classified Into Statin Benefit Groups.
Authors: Melander O, Shiffman D, Caulfield MP, Louie JZ, Rowland CM, Devlin JJ, Krauss RM.
J Am Coll Cardiol. 2015;65:2571-3.
Authors: Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW.
Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy.
Authors: Shiffman D, Trompet S, Louie JZ, Rowland CM, Catanese JJ, Iakoubova OA, Kirchgessner TG, Westendorp RG, de Craen AJ, Slagboom PE, Buckley BM, Stott DJ, Sattar N, Devlin JJ, Packard CJ, Ford I, Sacks FM, Jukema JW.
PLoS One. 2012;7:e38240.
Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease.
Authors: Shiffman D, Slawsky K, Fusfeld L, Devlin JJ, Goss TF.
Clin Ther. 2012;34:1387-1394.
Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.
Authors: Noori N, Caulfield MP, Salameh WA, Reitz RE, Nicholas SB, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K.
Clin J Am Soc Nephrol. 2011;6:2861-2870.
'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
Authors: Pierangeli SS, de Groot PG, Dlott J, Favaloro E, Harris EN, Lakos G, Ortel T, Meroni PL, Otomo K, Pengo V, Tincani A, Wong R, Roubey R.
Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory.
Quest Diagnostics Authors: Strom, C
Authors: Goos D, Crossley B, Zhang K, Buller-Burkle A, Jarvis M, Quan F, Peng M, Sun W.
Genet Med. 2012;14:95-100.
Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises.
Authors: Superko HR, Roberts R, Agatston A, Frohwein S, Reingold JS, White TJ, Sninsky JJ, Margolis B, Momary KM, Garrett BC, King SB, III.
Curr Atheroscler Rep. 2011;13:396-404.
Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.
Authors: Williams P, Pendyala L, Superko R.
BMC Med Genet. 2011;12:42.